Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/07/2025 ,inter alia, to consider and approve 1. To consider and discuss the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bacil Pharma Ltd has scheduled a Board meeting on 16th July 2025 to consider appointing a new Executive Director and Chief Financial Officer (CFO), and to formally accept the resignation of the current CFO. The current CFO, Jayesh R. Patil, has already submitted his resignation letter dated 11th July 2025, effective from 10th July 2025, after serving the company for around 18 years. The outcome of the board meeting will be communicated to the stock exchange afterwards. The company has its registered office in Andheri East, Mumbai, and is listed on BSE under script code 524516.
For shareholders, this signals a senior leadership transition at the finance function. Markets may watch closely for the identity and background of the incoming Executive Director and CFO, as the outgoing CFO had a long 18-year tenure. Until the new appointee is disclosed, there may be short-term uncertainty around financial leadership.